Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Immuron Ltd changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 4 | 7 | +3 |
| Shares | 7.09K | 39.3K | +32.2K (+453.9%) |
| Value | $13.3K | $101.6K | +$88.3K (+663.8%) |
New holders (4)
Institutions that held Immuron Ltd at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 23,842 | $61.0K | 0.00% |
| Two Sigma Securities, LLC | 10,860 | $28.6K | 0.00% |
| UBS Group AG | 1,076 | $2.83K | 0.00% |
| Rhumbline Advisers | 1,010 | $2.62K | 0.00% |
Sold out (1)
Institutions that held Immuron Ltd at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Global Wealth Management Investment Advisory, Inc. | 100 | $188 |